|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Revenue | |
| Cost of sales | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Sales and marketing | |
| General and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expense): | |
| Interest expense | |
| Interest income | |
| Change in fair value of warrant liabilities | |
| Total other income (expense), net | |
| Net loss | |
| Net loss and comprehensive loss | |
| Deemed dividend to preferred stockholders | |
| Net loss attributable to common stockholders | |
| Net loss per share attributable to common stockholders, basic | |
| Net loss per share attributable to common stockholders, diluted | |
| Weighted-average number of common shares used to compute basic net loss per share | |
| Weighted-average number of common shares used to compute diluted net loss per share |
Loading...